| Dr David Christensen, OD | |
|
1065 East Post Rd, Marion, IA 52302 | |
| (319) 377-2222 | |
| (319) 377-2967 |
| Full Name | Dr David Christensen |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 24 Years |
| Location | 1065 East Post Rd, Marion, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891775276 | NPI | - | NPPES |
| 21637 | Other | IA | BC/BS |
| 28986 | Other | IA | BC/BS |
| 410043671 | Other | RR MEDICARE | |
| 0461921 | Medicaid | IA | |
| 7236139 | Other | AETNA | |
| 21634 | Other | IA | BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 02182 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Linn County Eye Care Plc | 0749434041 | 8 |
News Archive
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Dexrazoxane for Injection, packaged in 250 mg and 500 mg Single-use Vials. This product is the generic version of Pharmacia & Upjohn's Zinecard® for Injection, a chemoprotective agent.
Anesthesiology researchers have shown that a device approved by the Food and Drug Administration to reduce the risk that patients will recall their surgery does not lower the risk of the problem, known as intraoperative awareness, any more than a less expensive method.
Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have identified how one type of bacteria, Yersinia, immobilizes the immune system in order to grow in the organs of mice. To do so, the researchers extended the use of a technique and suggest that it could be used to study other bacteria that use the same or similar means of infection.
One of the largest clinical trials done in infants with congenital (present at birth) heart diseases, published in the New England Journal of Medicine, shows that the increasingly common practice of using the drug clopidogrel (Plavix-) to reduce shunt-related blood flow issues is not effective in the dose studied.
› Verified 8 days ago
| Provider Name | Linn County Eye Care Plc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1598019408 PECOS PAC ID: 0749434041 Enrollment ID: O20130220000511 |
News Archive
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Dexrazoxane for Injection, packaged in 250 mg and 500 mg Single-use Vials. This product is the generic version of Pharmacia & Upjohn's Zinecard® for Injection, a chemoprotective agent.
Anesthesiology researchers have shown that a device approved by the Food and Drug Administration to reduce the risk that patients will recall their surgery does not lower the risk of the problem, known as intraoperative awareness, any more than a less expensive method.
Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have identified how one type of bacteria, Yersinia, immobilizes the immune system in order to grow in the organs of mice. To do so, the researchers extended the use of a technique and suggest that it could be used to study other bacteria that use the same or similar means of infection.
One of the largest clinical trials done in infants with congenital (present at birth) heart diseases, published in the New England Journal of Medicine, shows that the increasingly common practice of using the drug clopidogrel (Plavix-) to reduce shunt-related blood flow issues is not effective in the dose studied.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Christensen, OD 915 Robins Square Dr, Robins, IA 52328 Ph: (319) 377-2222 | Dr David Christensen, OD 1065 East Post Rd, Marion, IA 52302 Ph: (319) 377-2222 |
News Archive
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Dexrazoxane for Injection, packaged in 250 mg and 500 mg Single-use Vials. This product is the generic version of Pharmacia & Upjohn's Zinecard® for Injection, a chemoprotective agent.
Anesthesiology researchers have shown that a device approved by the Food and Drug Administration to reduce the risk that patients will recall their surgery does not lower the risk of the problem, known as intraoperative awareness, any more than a less expensive method.
Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have identified how one type of bacteria, Yersinia, immobilizes the immune system in order to grow in the organs of mice. To do so, the researchers extended the use of a technique and suggest that it could be used to study other bacteria that use the same or similar means of infection.
One of the largest clinical trials done in infants with congenital (present at birth) heart diseases, published in the New England Journal of Medicine, shows that the increasingly common practice of using the drug clopidogrel (Plavix-) to reduce shunt-related blood flow issues is not effective in the dose studied.
› Verified 8 days ago
Dr. Troy W Albrecht, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1415 Blairs Ferry Rd, Marion, IA 52302 Phone: 319-377-5343 Fax: 319-447-6119 | |
Linn County Eye Care Plc Optometrist Medicare: Medicare Enrolled Practice Location: 1065 E Post Rd, Marion, IA 52302 Phone: 319-377-2222 Fax: 319-377-2967 | |
Iowa Eye Care Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1065 E Post Rd, Marion, IA 52302 Phone: 319-377-2222 Fax: 319-377-2967 | |
Insight Vision Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 1415 Blairs Ferry Rd, Marion, IA 52302 Phone: 319-377-5343 Fax: 319-447-6119 | |
Dr. Kimberly Kay Cruise, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1065 East Post Road, Marion, IA 52302 Phone: 319-377-2222 Fax: 319-377-2967 | |
Dr. Dennis Wayne Francis, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1065 East Post Road, Marion, IA 52302 Phone: 319-377-2222 Fax: 319-377-2967 | |
Sigma Eyehealth Centers Optometrist Medicare: Medicare Enrolled Practice Location: 985 31st St, Marion, IA 52302 Phone: 319-377-9735 |